Fwiw, to me the sale of Constellation for $1.7B USD somewhat sets the market value for a mid-stage epigenetic cancer therapy. I hope Don can show at least a little business skill (what he is allegedly there for) and start getting similar type valuation for Zenith in future financings for the company. It can now be argued it is worth that neighbourhood.  An all out sale would be even better!!